GGrantIndex
← Search

CLINICAL QUALIFICATION OF DNA REPAIR DEFECTS AS BIOMARKERS IN METASTATIC PROSTATE CANCER USING INTEGRATED GENOMICS AND TISSUE-BASED FUNCTIONAL ASSAYS

$625,318FY2018Defense Health AgencyDOD

Fundacion Centro Nacional De Investigaciones Oncologicas Carlos Iii

Investigators

View source on USAspending →